Can HLA-G polymorphisms predict the development of cardiac allograft vasculopathy?

Human Immunology

Volumn 74, Issue 4, 2013, Pages 464-467

  Mociornita, Amelia G ^a   Lim Shon, Jongsung ^a   Joseph, Jemy M ^a   Ross, Heather J ^a   Rao, Vivek ^a   Delgado, Diego H ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN;

ADULT; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; DISEASE COURSE; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE FREQUENCY; GENOTYPE; GRAFT REJECTION; HEART TRANSPLANTATION; HLA-G ANTIGENS; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; PROGNOSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84875060529     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.12.014     Document Type: Article

References (30)

1. Menier C., Rouas-Freiss N., Favier B., LeMaoult J., Moreau P., Carosella E.D. Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule. Tissue Antigens 2010, 75(3):201-206.
2. Carosella E.D., Rouas-Freiss N., Paul P., Dausset J. HLA-G: a tolerance molecule from the major histocompatibility complex. Immunol today 1999, 20:20-60.
3. Carosella E.D. HLA-G: from feto-maternal tolerance to organ grafting. Bull Mem Acad R Med Belg 2009, 164(3-4):87-99.
4. Apps R., Gardner L., Moffetta A. A critical look at HLA-G. Trends in Immunol 2008, 29(7):313-321.
5. Carosella E.D., Moreau P., LeMaoult J., Rouas-Freissa N. HLA-G: from biology to clinical benefits. Trends in Immunol 2008, 29(3):125-132.
6. Naji A., Durrbach A., Carosella E.D., Rouas-Freiss N. Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways. Hum Immunol 2007, 68(4):233-239.
7. Riteau B., Rouas-Freiss N., Menier C., Paul P., Dausset J., Carosella E.D. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigenspecificCTL cytolysis. J Immunol 2001, 166(8):5018-5026.
8. LeMaoult J., Krawice-Radanne I., Dausset J., Carosella E.D. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci USA 2004, 101(18):7064-7069.
9. Ristich V., Liang S., Zhang W., Wu J., Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol 2005, 35(4):1133-1142.
10. Creput C., Durrbach A., Menier C., et al. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 2003, 39(4):587-594.
11. Creput C., Le Friec G., Bahri R., et al. Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients. Hum Immunol 2003, 64(11):1033-1038.
12. Basturk B., Karakayali F., Emiroglu R., et al. Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation. Transplant Proc 2006, 38(2):571-574.
13. Sheshgiri R., Rouas-Freiss N., Rao V., et al. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients. J Heart Lung Transplant 2008, 27(5):522-527.
14. Luque J., Torres M.I., Aumente M.D., et al. SHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation. Transpl Immunol 2006, 17(1):70-73.
15. Luque J., Torres M.I., Aumente M.D., et al. Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy. Hum Immunol 2006, 67(4-5):257-263.
16. Lila N., Amrein C., Guillemain R., Chevalier P., Fabiani J.N., Carpentier A. Soluble human leukocyte antigen-G: a new strategy for monitoring acute and chronic rejections after heart transplantation. J Heart Lung Transplant 2007, 26(4):421-422.
17. Hviid T.V., Rizzo R., Melchiorri L., Stignani M., Baricordi O.R. Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression. Hum Immunol 2006, 67(1-2):53-62.
18. Hviid T.V., Moller C., Sorensen S., Morling N. Co-dominant expression of the HLA-G gene and various forms of alternatively spliced HLA-G mRNA in human first trimester trophoblast. Hum Immunol 1998, 59(2):87-98.
19. Hviid T.V., Rizzo R., Christiansen O.B., Melchiorri L., Lindhard A., Baricordi O.R. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004, 56(3):135-141.
20. Veit T.D., Cordero E.A., Mucenic T., et al. Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus. Lupus 2009, 18(5):424-430.
21. Rousseau P., Le Discorde M., Mouillot G., Marcou C., Carosella E.D., Moreau P. The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003, 64(11):1005-1010.
22. Chen X.Y., Yan W.H., Lin A., Xu H.H., Zhang J.G., Wang X.X. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 2008, 72(4):335-341.
23. Twito T., Joseph J., Mociornita A., Rao V., Ross H., Delgado D.H. The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients. J Heart Lung Transplant 2011, 30(7):778-782.
24. Lila N., Amrein C., Guillemain R., et al. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002, 105(16):1949-1954.
25. Mehra M.R., Crespo-Leiro M.G., Dipchand A., et al. International society for heart and lung transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy. J Heart Lung Transplant 2010, 29(7):717-727.
26. Crispim J.C., Duarte R.A., Soares C.P., et al. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection. Transpl Immunol 2008, 18(4):361-367.
27. Hviid T.V., Hylenius S., Rorbye C., Nielsen L.G. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003, 55(2):63-79.
28. La Nasa G., Littera R., Locatelli F., et al. The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia. Br J Haematol 2007, 139(2):284-288.
29. Torres M.I., Luque J., Lorite P., et al. 14-base pair polymorphism of human leukocyte antigen-G as genetic determinant in heart transplantation and cyclosporine therapy monitoring. Hum Immunol 2009, 70(10):830-835.
30. Pinney S.P., Mancini D. Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention, and treatment. Curr Opin Cardiol 2004, 19(2):170-176.